Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-1,026,6623 Transition metal catalysts for olefin polymerization
In one aspect, a chelating phosphine-phosphonic diamide (PPDA) ligand is described herein for constructing transition metal complexes operable for catalysis of...
US-1,026,6622 Olefin polymerization catalyst system comprising mesoporous organosilica support
A catalyst system comprising a combination of: 1) one or more catalyst compounds having at least one nitrogen linkage and at least one oxygen linkage to a...
US-1,026,6621 Metal-phosphinesulfonate acetonitrile complex for insertion copolymerization of functional olefins
The present invention discloses nitrile ligated transition metal-phosphinobenzene-sulfonate complex of formula (I) as catalyst for insertion-copolymerization of...
US-1,026,6620 Coating agents and coated articles
The invention describes novel coating agents that include a polymer, one or more latent reactive groups and one or more noncovalent linking groups, the...
US-1,026,6619 Long-chain branched polymers and production processes
This invention relates to a process for forming a long-chain branched polymer and a long-chain branched polymer resulting from the process. The process...
US-1,026,6618 Chromium-based catalyst compositions for olefin polymerization
Modified chromium-based catalyst compositions for olefin polymerization are disclosed. The modifiers prevent or reduce catalyst particle aggregation providing...
US-1,026,6617 Cationic copolymer and use thereof in lost circulation additive
A cationic copolymer represented by the following formula (I) has a viscosity average molecular weight in a range from 2 million to 10 million. In the cationic...
US-1,026,6616 Light induced free radical and/or cationic photopolymerization method
The present invention relates to a new method of light induced photopolymerization under mild irradiation conditions, copper initiator complexes to be used in...
US-1,026,6615 Method for preparing acrylonitrile-butadiene-styrene graft copolymer and acrylonitrile-butadiene-styrene...
The present invention relates to a method for preparing an acrylonitrile-butadiene-styrene graft copolymer having improved impact strength, which comprises: a...
US-1,026,6614 Modified conjugated diene polymer, modified rubber composition comprising same, and method for preparing...
Disclosed are a modified conjugated diene-based polymer represented by Chemical Formula 2a or 2b defined herein and a method of preparing the same.
US-1,026,6613 Conjugated diene polymer and method of production of conjugated diene polymer
A conjugated diene polymer represented by the following formula (1) or the following formula (2): ##STR00001## (wherein, in the formula (1) and in the formula...
US-1,026,6612 Heparan sulphates
A novel class of structurally and functionally related isolated Heparan sulphate is disclosed. The novel class of Heparan sulphates has been found to bind FGF2...
US-1,026,6611 Hybrid cooperative complexes of hyaluronic acid
Describes cooperative hybrid complexes of hyaluronic acid, a simple and economical method for production thereof and use thereof in the area of medicine,...
US-1,026,6610 Method of processing and fractionating biomass and use of fractions thus obtained
The present invention relates to a method of treating biomass, comprising providing a lignocellulosic biomass feedstock; contacting the biomass feedstock in a...
US-1,026,6609 Immunomodulating beta-1,6-D-glucans
This invention relates to modifications of .beta.-1,6-D-glucans, e.g., structures according to Formula (I), and the ability of these compositions to modulate an...
US-1,026,6608 Fabs-in-tandem immunoglobulin and uses thereof
The present invention provides multivalent and multispecific binding proteins that are capable of binding two or more antigens, or two or more epitopes. The...
US-1,026,6607 Antibody binding to TFPI and composition comprising the same
The present invention relates to an antibody that binds specifically to a tissue factor pathway inhibitor (TFPI), a nucleic acid encoding the antibody, a vector...
US-1,026,6606 Method for purifying Cys-linked antibody-drug conjugates
The present invention relates to a method for purifying a mixture of cysteine-linked antibody-drug conjugates, wherein the amount of non-conjugated antibody is...
US-1,026,6605 Efficacy of anti-trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refractory to checkpoint...
The present invention relates to therapeutic ADCs comprising SN-38 attached to an anti-Trop-2 antibody or antigen-binding antibody fragment, more particularly...
US-1,026,6604 CD27L antigen binding proteins
The present invention relates to CD27L antigen binding proteins, such an antibodies, polynucleotides encoding said CD27l antigen binding proteins, antibody drug...
US-1,026,6603 Targeted therapy to restore radioactive iodine transport in thyroid cancer
The invention includes method, pharmaceutical compositions and uses thereof for treating patients with Papillary Thyroid Carcinoma (PTC) using a Platelet...
US-1,026,6602 Compositions and methods for diagnosis and treatment of hepatic cancers
The present invention relates to methods of treating liver cancer using a Notch signaling inhibitor. Compositions and methods for the treatment of liver cancers...
US-1,026,6601 Recombinant obligate anaerobic gram-positive bacteria
An object of the present invention is to effectively induce cancer cell apoptosis using the anti-TRAIL-R1 antibody(ies) and the anti-TRAIL-R2 antibody(ies) and...
US-1,026,6600 Diagnostic anti-CD95L antibody
The present invention relates to a specific CD95L antibody and to the use thereof in the diagnosis of a cancer disease.
US-1,026,6599 Antibodies which bind to the human CC chemokine receptor 4 and uses thereof
The present invention provides antibodies which bind to an epitope in the extracellular domain of human CC chemokine receptor 4 (CCR4) and which are capable of...
US-1,026,6598 Dual receptor antagonistic antigen-binding proteins and uses thereof
This disclosure relates to antagonistic dual receptor antigen-binding proteins, e.g. antibodies and methods of using the dual receptor antibodies for treatment...
US-1,026,6597 Anti-CLL-1 antibodies and immunoconjugates
The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
US-1,026,6596 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
The disclosure provides a method for immunotherapy of a subject afflicted with cancer, comprises administering to the subject a composition comprising a...
US-1,026,6595 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
The disclosure provides a method for immunotherapy of a subject afflicted with cancer, comprises administering to the subject a composition comprising a...
US-1,026,6594 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
The disclosure provides a method for immunotherapy of a subject afflicted with cancer, comprises administering to the subject a composition comprising a...
US-1,026,6593 Human CD3 binding antibody
The invention is among others concerned with human CD3 binding antibodies comprising a heavy chain and light chain wherein said heavy chain comprises a variable...
US-1,026,6592 Drug regulated transgene expression
The present invention provides nucleic acids, vectors, host cells, methods and compositions to confer and/or augment immune responses mediated by cellular...
US-1,026,6591 Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
The present invention provides isolated monoclonal antibodies that specifically bind LAG-3, and have optimized functional properties compared to previously...
US-1,026,6590 Methods related to biologics
The present invention relates to the characterization and production of biologics.
US-1,026,6589 Heavy chain only antibodies to ANG-2
Disclosed herein are monospecific HCAb antibodies with antigen-binding specificity to ANG-2 and bispecific antibodies with antigen-binding specificities to...
US-1,026,6588 Method of treating osteoarthritis with an antibody to NGF
Methods are disclosed for treating osteoarthritis in a human subject in need thereof, comprising administering to the subject a therapeutically effective amount...
US-1,026,6587 Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in...
The present invention is directed to methods of inhibiting or preventing photophobia in subjects in need thereof using anti-CGRP antibodies or antibody...
US-1,026,6586 Targeting CLPTM1L for treatment and prevention of cancer
Provided herein are therapeutic agents having specificity for human CLPTM1 L polypeptide, including therapeutic agents comprising one or more CLPTM1 L-targeting...
US-1,026,6585 Methods of treating brain injury
Embodiments of the invention are directed to compositions and methods related to Tau oligomers and Tau oligomer specific antibodies and their use in detecting...
US-1,026,6583 Variant factor VIII polypeptides and methods of their production and use
This disclosure relates to variant Factor VIII polypeptides comprising an amino acid substitution at one or more positions within one or both of the thrombin...
US-1,026,6582 GPR156 variants and uses thereof
The disclosure provides nucleic acids, including cDNA, comprising alterations that encode aspartic acid at a position corresponding to position 533 of the human...
US-1,026,6581 Uterine cancer treatments
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates...
US-1,026,6580 Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
The invention provides compositions and methods for adoptive T cell therapy in treating a variety of disorders including cancer, infections, and autoimmune...
US-1,026,6579 Synthetic somatostatin receptor ligands
Disclosed are Somatostatin receptor ligands comprising a peptide moiety, pharmaceutical compositions and uses thereof. Disclosed are also synthetic Somatostatin...
US-1,026,6578 Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
The present disclosure generally relates to modified relaxin polypeptides, such as modified human relaxin 2 polypeptides, comprising a non-naturally encoded...
US-1,026,6577 GLP-1 derivatives, and uses thereof
The present invention relates to tri-acylated GLP-1 derivatives, acylated at positions corresponding to positions (18, 22, 30), (18, 26, 37), (18, 27, 37), (26,...
US-1,026,6576 Polypeptides comprising an ice-binding activity
The present invention relates to novel polypeptides comprising an ice-binding capability resulting in an ice crystal formation and/or growth reducing or...
US-1,026,6575 Plant transcriptional regulators
The invention relates to plant transcription factor polypeptides, polynucleotides that encode them, homologs from a variety of plant species, and methods of...
US-1,026,6574 Tuberculosis compositions and methods of using the same
The present disclosure provides fusion proteins comprising Mycobacterium tuberculosis (Mtb) antigens, nucleic acid molecules encoding the same, vectors...
US-1,026,6573 Cytotoxic factors for modulating cell death
Cytotoxic factors having use in modulating cell death, and their use in methods of treating necrosis or apoptosis-related conditions are disclosed. The...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.